<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940418-0-00007</title>
	</head>
	<body>
		<main>
			<p><!-- PJG ITAG l=10 g=1 f=2 --> EFFECTIVE DATE: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  April 18, 1994. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> <!-- PJG STAG 4700 -->  <!-- PJG ITAG l=94 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=50 g=1 f=1 -->   <USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES</USDEPT>  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>Food and Drug Administration</USBUREAU> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=52 g=1 f=1 -->  <CFRNO>21 CFR Part 558</CFRNO> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 --> New Animal Drugs for Use in Animal Feeds; Laidlomycin Propionate Potassium <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <AGENCY> <!-- PJG ITAG l=10 g=1 f=2 --> AGENCY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Food and Drug Administration, HHS. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </AGENCY> <ACTION> <!-- PJG ITAG l=10 g=1 f=2 --> ACTION: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Final rule. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=59 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </ACTION> <SUMMARY> <!-- PJG ITAG l=10 g=1 f=2 --> SUMMARY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the approval of a new animal drug application (NADA) filed by Syntex Animal Health, Division of Syntex Agribusiness, Inc. The NADA provides for the use of laidlomycin propionate potassium (CATTLYST <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=6 f=2 --> &reg; <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> ) Type A medicated article to make Type B and Type C medicated feeds for improved feed efficiency and increased rate of weight gain in cattle fed in confinement for slaughter.  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </SUMMARY> <DATE> <!-- PJG ITAG l=10 g=1 f=2 --> EFFECTIVE DATE: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  April 18, 1994. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </DATE> <FURTHER> <!-- PJG ITAG l=10 g=1 f=2 --> FOR FURTHER INFORMATION CONTACT: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Daniel A. Benz, Center for Veterinary Medicine (HFV&hyph;126), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301&hyph;594&hyph;1638. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </FURTHER> <SUPPLEM> <!-- PJG ITAG l=10 g=1 f=2 --> SUPPLEMENTARY INFORMATION: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Syntex Animal Health, Division of Syntex Agribusiness, Inc., 3401 Hillview Ave., Palo Alto, CA 94304, filed NADA 141&hyph;025 which provides for the use of 50 grams (g) per pound of laidlomycin propionate potassium (CATTLYST <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=6 f=2 --> &reg; <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> ) Type A medicated article to make Type B and Type C medicated feeds for improved feed efficiency and increased rate of weight gain in cattle fed in confinement for slaughter. The Type C feed contains 5 g of laidlomycin propionate potassium per ton of feed to provide not less than 30 milligrams (mg) and not more than 75 mg per head per day for improved feed efficiency and increased rate of weight gain, and 5 to 10 g of laidlomycin propionate potassium per ton of feed to provide not less than 30 mg and not more than 150 mg per head per day for improved feed efficiency.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The NADA is approved as of March 4, 1994, and the regulations are amended in part 558 (21 CFR part 558) by adding laidlomycin propionate potassium to the Category I table in &sect;558.4(d) and by adding new &sect;558.305 to reflect the approval. The basis for approval is discussed in the freedom of information summary.  <!-- PJG 0012 frnewline --> In accordance with the freedom of information provisions of part 20 (21 CFR part 20) and &sect;514.11(e)(2)(ii) (21 CFR 514.11(e)(2)(ii)), a summary of safety and effectiveness data and information submitted to support approval of this application may be seen in the Dockets Management Branch (HFA&hyph;305), Food and Drug Administration, rm. 1&hyph;23, 12420 Parklawn Dr., Rockville, MD 20857, between 9 a.m. and 4 p.m., Monday through Friday. <!-- PJG 0012 frnewline --> Section 512(c)(2)(F)(i) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 360b(c)(2)(F)(i) provides a 5-year period of exclusivity to this original NADA beginning March 4, 1994, because no active ingredient (including any ester or salt of the active ingredient) has been approved in any other application under section 512(b)(1) of the act. <!-- PJG 0012 frnewline --> The agency has carefully considered the potential environmental effects of this action. FDA has concluded that the action will not have a significant impact on the human environment, and that an environmental impact statement is not required. The agency's finding of no significant impact and the evidence supporting that finding, contained in an environmental assessment, may be seen in the Dockets Management Branch (address above) between 9 a.m. and 4 p.m., Monday through Friday. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> List of Subjects 21 CFR Part 558  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Animal drugs, Animal feeds.  <!-- PJG 0012 frnewline --> Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 558 is amended as follows: <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=52 g=1 f=1 --> PART 558_NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 1. The authority citation for 21 CFR part 558 continues to read as follows: <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=4 --> Authority: <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  Secs. 512, 701 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b, 371). <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> 2. Section 558.4 is amended in paragraph (d) in the ``Category I'' table by alphabetically adding a new entry for ``Laidlomycin propionate potassium'' to read as follows:  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;558.4  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Medicated feed applications. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * * <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (d) * * * <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * * <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <TABLE>  <!-- PJG tableformat 4,L1,i1,s50,10,r20,r15 -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=95 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=95 g=1 f=4 --> Category <!-- PJG /ITAG -->  <!-- PJG ITAG l=95 g=1 f=1 -->  I <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Drug  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Assay limits  <!-- PJG 0034 unknown --> percent <!-- PJG /ITAG -->  <!-- PJG ITAG l=95 g=5 f=1 --> 1 <!-- PJG /ITAG -->  <!-- PJG ITAG l=95 g=1 f=1 -->  type A  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Type B maximum (200x) <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Assay limits percent1  <!-- PJG 0034 unknown --> type B/C <!-- PJG /ITAG -->  <!-- PJG ITAG l=95 g=5 f=1 --> 2 <!-- PJG /ITAG -->  <!-- PJG ITAG l=95 g=1 f=1 -->  <!-- PJG 007 0152 intable -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=28 g=1 f=1 --> &blank;*&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;*&blank;&blank; <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 --> Laidlomycin propionate  <!-- PJG 0034 unknown --> potassium <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> 90&hyph;110  <!-- PJG 007 0104 intable --> 1 g/pound (0.22%)  <!-- PJG 007 0104 intable --> 90&hyph;115/85&hyph;115 <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=28 g=1 f=1 --> &blank;*&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;*&blank;&blank; <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 007 0146 intable --> 1Percent of labeled amount. <!-- PJG 0012 frnewline -->  <!-- PJG 007 0146 intable --> 2Values given represent ranges for either Type B or Type C medicated feeds. For those drugs that have two range limits, the first set is for a Type B medicated feed and the second set is for a Type C medicated feed. These values (ranges) have been assigned in order to provide for the possibility of dilution of a Type B medicated feed with lower assay limits to make Type C medicated feed. <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * * <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 3. New &sect;558.305 is added to subpart B to read as follows: <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;558.305  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Laidlomycin propionate potassium. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (a)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Approvals <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> . Type A medicated articles: 50 grams per pound to 000033 in &sect;510.600(c) of this chapter. <!-- PJG 0012 frnewline --> (b)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Conditions of use <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> . Used in cattle feed as follows: <!-- PJG 0012 frnewline --> (1)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Amount <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> . Laidlomycin propionate potassium, 5 grams per ton.  <!-- PJG 0012 frnewline --> (i)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Indications for use <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> . For improved feed efficiency and increased rate of weight gain.  <!-- PJG 0012 frnewline --> (ii)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Limitations <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> . Feed only to cattle being fed in confinement for slaughter. Feed continuously in a Type C feed at a rate of 30 to 75 milligrams per head per day.  <!-- PJG 0012 frnewline --> (2)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Amount <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> . Laidlomycin propionate potassium, 5 to 10 grams per ton.  <!-- PJG 0012 frnewline --> (i)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Indications for use <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> . For improved feed efficiency.  <!-- PJG 0012 frnewline --> (ii)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Limitations <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> . Feed only to cattle being fed in confinement for slaughter. Feed continuously in a Type C feed at a rate of 30 to 150 milligrams per head per day.  <!-- PJG 0012 frnewline --> (3)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Special considerations <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> _(i) Do not allow horses or other equines access to feeds containing laidlomycin propionate potassium. <!-- PJG 0012 frnewline --> (ii) The safety of laidlomycin propionate potassium in unapproved species has not been established. <!-- PJG 0012 frnewline --> (iii) Not for use in animals intended for breeding.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: April 8, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SUPPLEM> <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Richard H. Teske, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Acting Director, Center for Veterinary Medicine. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;9189 Filed 4&hyph;15&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4160&hyph;01&hyph;F <!-- PJG /ITAG --> </BILLING>  <!-- PJG /STAG --></p>
		</main>
</body></html>
            